Frederick E. Durr
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Viral-associated cancers and disorders
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 6
- Immunology 11
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Roslyn E. Wallace (6 shared papers)K. C. Murdock (5 shared papers)R. V. Citarella (2 shared papers)Lois M. Hinman (2 shared papers)Robert B. Angier (2 shared papers)Ana T. Menendez (2 shared papers)Janis Upeslacis (2 shared papers)Philip R. Hamann (2 shared papers)
- Journals
- The Journal of Immunology (2 papers)Cancer Investigation (2 papers)Journal of Medicinal Chemistry (2 papers)International Journal of Cancer (2 papers)Cellular Immunology (2 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Frederick E. Durr
40 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Toxicology 128
- Oncology 501
- Radiology, Nuclear Medicine and Imaging 179
- Immunology 162
- Hematology 85
Countries citing papers authored by Frederick E. Durr
This map shows the geographic impact of Frederick E. Durr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick E. Durr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick E. Durr more than expected).
Fields of papers citing papers by Frederick E. Durr
This network shows the impact of papers produced by Frederick E. Durr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick E. Durr. The network helps show where Frederick E. Durr may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick E. Durr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 259 | |
| 2 | Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. | 1993 | 202 |
| 3 | Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. | 1979 | 137 |
| 4 | 1983 | 118 | |
| 5 | 1970 | 78 | |
| 6 | 2005 | 62 | |
| 7 | 1985 | 60 | |
| 8 | Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. | 1982 | 32 |
| 9 | 1975 | 31 | |
| 10 | 1970 | 31 | |
| 11 | P-glycoprotein mediates profound resistance to bisantrene. | 1994 | 24 |
| 12 | 1986 | 23 | |
| 13 | 1988 | 22 | |
| 14 | 1987 | 19 | |
| 15 | 1984 | 17 | |
| 16 | 1986 | 17 | |
| 17 | 1987 | 15 | |
| 18 | Immunotherapy of a murine lymphoma by adoptive transfer of syngeneic macrophages activated with bisantrene. | 1986 | 13 |
| 19 | 1975 | 13 | |
| 20 | 1985 | 12 |
About Frederick E. Durr
Frederick E. Durr is a scholar working on Oncology, Immunology, Toxicology, Virology and Organic Chemistry, having authored 42 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (6 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers), Respiratory viral infections research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Toxicology (128 citations), Oncology (501 citations), Radiology, Nuclear Medicine and Imaging (179 citations), Immunology (162 citations) and Hematology (85 citations). Frederick E. Durr has collaborated with scholars based in United States and Germany. Frequent co-authors include Roslyn E. Wallace, K. C. Murdock, R. V. Citarella, Lois M. Hinman, Robert B. Angier, Ana T. Menendez, Janis Upeslacis, Philip R. Hamann, R. E. Wallace and P. F. FABIO. Their work appears in journals such as The Journal of Immunology, Cancer Investigation, Journal of Medicinal Chemistry, International Journal of Cancer and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.